ENTEGRIS INC (1ENTG.MI) Stock Fundamental Analysis

BIT:1ENTG • US29362U1043

101.96 EUR
+23.9 (+30.62%)
Last: Feb 2, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

Taking everything into account, 1ENTG scores 3 out of 10 in our fundamental rating. 1ENTG was compared to 66 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and the financial health of 1ENTG get a neutral evaluation. Nothing too spectacular is happening here. 1ENTG has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • 1ENTG had positive earnings in the past year.
  • 1ENTG had a positive operating cash flow in the past year.
  • 1ENTG had positive earnings in 4 of the past 5 years.
  • 1ENTG had a positive operating cash flow in 4 of the past 5 years.
1ENTG.MI Yearly Net Income VS EBIT VS OCF VS FCF1ENTG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

  • 1ENTG has a worse Return On Assets (3.43%) than 62.86% of its industry peers.
  • 1ENTG has a Return On Equity (7.41%) which is in line with its industry peers.
  • The Return On Invested Capital of 1ENTG (4.75%) is worse than 62.86% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for 1ENTG is significantly below the industry average of 14.33%.
  • The last Return On Invested Capital (4.75%) for 1ENTG is above the 3 year average (4.27%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.43%
ROE 7.41%
ROIC 4.75%
ROA(3y)2.53%
ROA(5y)6.1%
ROE(3y)6.57%
ROE(5y)13%
ROIC(3y)4.27%
ROIC(5y)7.78%
1ENTG.MI Yearly ROA, ROE, ROIC1ENTG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • The Profit Margin of 1ENTG (8.95%) is comparable to the rest of the industry.
  • 1ENTG's Profit Margin has declined in the last couple of years.
  • 1ENTG has a Operating Margin (15.55%) which is in line with its industry peers.
  • 1ENTG's Operating Margin has improved in the last couple of years.
  • The Gross Margin of 1ENTG (44.89%) is worse than 61.43% of its industry peers.
  • In the last couple of years the Gross Margin of 1ENTG has remained more or less at the same level.
Industry RankSector Rank
OM 15.55%
PM (TTM) 8.95%
GM 44.89%
OM growth 3Y-11.8%
OM growth 5Y1.63%
PM growth 3Y-20.23%
PM growth 5Y-10.83%
GM growth 3Y-0.16%
GM growth 5Y0.5%
1ENTG.MI Yearly Profit, Operating, Gross Margins1ENTG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1ENTG is destroying value.
  • 1ENTG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
1ENTG.MI Yearly Shares Outstanding1ENTG.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
1ENTG.MI Yearly Total Debt VS Total Assets1ENTG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • 1ENTG has an Altman-Z score of 3.45. This indicates that 1ENTG is financially healthy and has little risk of bankruptcy at the moment.
  • 1ENTG has a Altman-Z score of 3.45. This is in the lower half of the industry: 1ENTG underperforms 60.00% of its industry peers.
  • The Debt to FCF ratio of 1ENTG is 11.67, which is on the high side as it means it would take 1ENTG, 11.67 years of fcf income to pay off all of its debts.
  • 1ENTG has a worse Debt to FCF ratio (11.67) than 67.14% of its industry peers.
  • A Debt/Equity ratio of 0.99 indicates that 1ENTG is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.99, 1ENTG is doing worse than 90.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF 11.67
Altman-Z 3.45
ROIC/WACC0.46
WACC10.32%
1ENTG.MI Yearly LT Debt VS Equity VS FCF1ENTG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 3.44 indicates that 1ENTG has no problem at all paying its short term obligations.
  • 1ENTG's Current ratio of 3.44 is fine compared to the rest of the industry. 1ENTG outperforms 74.29% of its industry peers.
  • 1ENTG has a Quick Ratio of 2.13. This indicates that 1ENTG is financially healthy and has no problem in meeting its short term obligations.
  • 1ENTG has a Quick ratio of 2.13. This is in the better half of the industry: 1ENTG outperforms 74.29% of its industry peers.
Industry RankSector Rank
Current Ratio 3.44
Quick Ratio 2.13
1ENTG.MI Yearly Current Assets VS Current Liabilites1ENTG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for 1ENTG have decreased by -8.33% in the last year.
  • The Earnings Per Share has been growing slightly by 1.68% on average over the past years.
EPS 1Y (TTM)-8.33%
EPS 3Y-9.74%
EPS 5Y1.68%
EPS Q2Q%-16.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.05%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.03% on average over the next years. This is quite good.
  • 1ENTG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.01% yearly.
EPS Next Y20.14%
EPS Next 2Y23.63%
EPS Next 3Y19.32%
EPS Next 5Y18.03%
Revenue Next Year6.09%
Revenue Next 2Y7.48%
Revenue Next 3Y7.2%
Revenue Next 5Y8.01%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
1ENTG.MI Yearly Revenue VS Estimates1ENTG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
1ENTG.MI Yearly EPS VS Estimates1ENTG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 43.95 indicates a quite expensive valuation of 1ENTG.
  • Compared to the rest of the industry, the Price/Earnings ratio of 1ENTG is on the same level as its industry peers.
  • The average S&P500 Price/Earnings ratio is at 26.99. 1ENTG is valued rather expensively when compared to this.
  • A Price/Forward Earnings ratio of 36.61 indicates a quite expensive valuation of 1ENTG.
  • 1ENTG's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. 1ENTG is more expensive than 67.14% of the companies in the same industry.
  • 1ENTG's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 43.95
Fwd PE 36.61
1ENTG.MI Price Earnings VS Forward Price Earnings1ENTG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 1ENTG's Enterprise Value to EBITDA is on the same level as the industry average.
  • 1ENTG's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 55.43
EV/EBITDA 24.62
1ENTG.MI Per share data1ENTG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as 1ENTG's earnings are expected to grow with 19.32% in the coming years.
PEG (NY)2.18
PEG (5Y)26.13
EPS Next 2Y23.63%
EPS Next 3Y19.32%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • 1ENTG has a yearly dividend return of 0.31%, which is pretty low.
  • 1ENTG's Dividend Yield is comparable with the industry average which is at 0.75.
  • With a Dividend Yield of 0.31, 1ENTG pays less dividend than the S&P500 average, which is at 1.81.
Industry RankSector Rank
Dividend Yield 0.31%

5.2 History

  • On average, the dividend of 1ENTG grows each year by 6.05%, which is quite nice.
Dividend Growth(5Y)6.05%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 1ENTG pays out 21.08% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of 1ENTG is growing, but earnings are growing more, so the dividend growth is sustainable.
DP21.08%
EPS Next 2Y23.63%
EPS Next 3Y19.32%
1ENTG.MI Yearly Income VS Free CF VS Dividend1ENTG.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M
1ENTG.MI Dividend Payout.1ENTG.MI Dividend Payout, showing the Payout Ratio.1ENTG.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ENTEGRIS INC

BIT:1ENTG (2/2/2026, 7:00:00 PM)

101.96

+23.9 (+30.62%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-10
Earnings (Next)05-05
Inst Owners118.63%
Inst Owner ChangeN/A
Ins Owners0.35%
Ins Owner ChangeN/A
Market Cap15.46B
Revenue(TTM)N/A
Net Income(TTM)288.44M
Analysts75.79
Price Target101.23 (-0.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.31%
Yearly Dividend0.34
Dividend Growth(5Y)6.05%
DP21.08%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.28%
Min EPS beat(2)-2.69%
Max EPS beat(2)2.12%
EPS beat(4)2
Avg EPS beat(4)0.29%
Min EPS beat(4)-3.94%
Max EPS beat(4)5.65%
EPS beat(8)4
Avg EPS beat(8)1.73%
EPS beat(12)8
Avg EPS beat(12)5.46%
EPS beat(16)10
Avg EPS beat(16)3.35%
Revenue beat(2)1
Avg Revenue beat(2)0.44%
Min Revenue beat(2)-1.6%
Max Revenue beat(2)2.48%
Revenue beat(4)2
Avg Revenue beat(4)-0.49%
Min Revenue beat(4)-4.03%
Max Revenue beat(4)2.48%
Revenue beat(8)3
Avg Revenue beat(8)-0.91%
Revenue beat(12)4
Avg Revenue beat(12)-0.91%
Revenue beat(16)6
Avg Revenue beat(16)-0.54%
PT rev (1m)16.98%
PT rev (3m)N/A
EPS NQ rev (1m)-0.81%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.09%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.26%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 43.95
Fwd PE 36.61
P/S 5.69
P/FCF 55.43
P/OCF 26.98
P/B 4.71
P/tB N/A
EV/EBITDA 24.62
EPS(TTM)2.32
EY2.28%
EPS(NY)2.79
Fwd EY2.73%
FCF(TTM)1.84
FCFY1.8%
OCF(TTM)3.78
OCFY3.71%
SpS17.92
BVpS21.64
TBVpS-5.6
PEG (NY)2.18
PEG (5Y)26.13
Graham Number33.61
Profitability
Industry RankSector Rank
ROA 3.43%
ROE 7.41%
ROCE 6.33%
ROIC 4.75%
ROICexc 5%
ROICexgc 14.39%
OM 15.55%
PM (TTM) 8.95%
GM 44.89%
FCFM 10.26%
ROA(3y)2.53%
ROA(5y)6.1%
ROE(3y)6.57%
ROE(5y)13%
ROIC(3y)4.27%
ROIC(5y)7.78%
ROICexc(3y)4.5%
ROICexc(5y)9.07%
ROICexgc(3y)14.12%
ROICexgc(5y)21.22%
ROCE(3y)5.69%
ROCE(5y)10.38%
ROICexgc growth 3Y-20.91%
ROICexgc growth 5Y-5.15%
ROICexc growth 3Y-32.38%
ROICexc growth 5Y-11.06%
OM growth 3Y-11.8%
OM growth 5Y1.63%
PM growth 3Y-20.23%
PM growth 5Y-10.83%
GM growth 3Y-0.16%
GM growth 5Y0.5%
F-Score7
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF 11.67
Debt/EBITDA 4.36
Cap/Depr 90.77%
Cap/Sales 10.82%
Interest Coverage 2.58
Cash Conversion 76.76%
Profit Quality 114.68%
Current Ratio 3.44
Quick Ratio 2.13
Altman-Z 3.45
F-Score7
WACC10.32%
ROIC/WACC0.46
Cap/Depr(3y)122.77%
Cap/Depr(5y)123.45%
Cap/Sales(3y)12.3%
Cap/Sales(5y)10.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.33%
EPS 3Y-9.74%
EPS 5Y1.68%
EPS Q2Q%-16.67%
EPS Next Y20.14%
EPS Next 2Y23.63%
EPS Next 3Y19.32%
EPS Next 5Y18.03%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.05%
Revenue Next Year6.09%
Revenue Next 2Y7.48%
Revenue Next 3Y7.2%
Revenue Next 5Y8.01%
EBIT growth 1Y7.65%
EBIT growth 3Y-1.1%
EBIT growth 5Y17.17%
EBIT Next Year21.88%
EBIT Next 3Y14.37%
EBIT Next 5Y12.55%
FCF growth 1Y834.38%
FCF growth 3Y18.52%
FCF growth 5Y3.21%
OCF growth 1Y32.97%
OCF growth 3Y16.41%
OCF growth 5Y10.57%

ENTEGRIS INC / 1ENTG.MI FAQ

What is the ChartMill fundamental rating of ENTEGRIS INC (1ENTG.MI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to 1ENTG.MI.


Can you provide the valuation status for ENTEGRIS INC?

ChartMill assigns a valuation rating of 1 / 10 to ENTEGRIS INC (1ENTG.MI). This can be considered as Overvalued.


What is the profitability of 1ENTG stock?

ENTEGRIS INC (1ENTG.MI) has a profitability rating of 4 / 10.


What are the PE and PB ratios of ENTEGRIS INC (1ENTG.MI) stock?

The Price/Earnings (PE) ratio for ENTEGRIS INC (1ENTG.MI) is 43.95 and the Price/Book (PB) ratio is 4.71.


What is the financial health of ENTEGRIS INC (1ENTG.MI) stock?

The financial health rating of ENTEGRIS INC (1ENTG.MI) is 4 / 10.